Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Drummond, Christopher A ^a   Brewster, Pamela S ^a   He, Wencan ^b   Ren, Kaili ^b   Xie, Yanmei ^b   Tuttle, Katherine R ^c   Haller, Steven T ^a   Jamerson, Kenneth ^d   Dworkin, Lance D ^a   Cutlip, Donald E ^e   Murphy, Timothy P ^f   D'Agostino, Ralph B ^e   Henrich, William L ^g   Tian, Jiang ^a   Shapiro, Joseph I ^h   Cooper, Christopher J ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^f BROWN UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ESTIMATED GLOMERULAR FILTRATION RATE; ETHNICITY; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PERIPHERAL VASCULAR DISEASE; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; SEX; SMOKING; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMPLICATION; GLOMERULUS FILTRATION RATE; PATHOPHYSIOLOGY; TOBACCO; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; RENAL ARTERY OBSTRUCTION; SMOKING; TOBACCO;

EID: 85015881832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0173562     Document Type: Article

References (41)

1. Centers for Disease C, Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004.MMWR Morbidity and mortality weekly report. 2008; 57 (45):1226-8. Epub 2008/11/15. PMID: 19008791
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA: the journal of the American Medical Association. 2004; 291(10):1238-45. Epub 2004/03/11. https://doi.org/10.1001/jama.291.10.1238 PMID:15010446
3. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W, et al. Smoking as a risk factor for endstage renal failure in men with primary renal disease. Kidney international. 1998; 54(3):926-31. Epub 1998/09/12. https://doi.org/10.1046/j.1523-1755.1998.00067.x PMID:9734618
4. Orth SR. Smoking and the Kidney. Journal of the American Society of Nephrology. 2002; 13(6):1663-72. PMID: 12039997
5. Orth SR. Cigarette smoking: an important renal risk factor-far beyond carcinogenesis. Tobacco induced diseases. 2002; 1(2):137-55. Epub 2002/01/01. PubMed Central PMCID: PMCPMC2671650. https://doi.org/10.1186/1617-9625-1-2-137 PMID:19570254
6. Orth SR, Hallan SI. Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients-Absence of Evidence or Evidence of Absence? Clinical Journal of the American Society of Nephrology. 2008; 3(1):226-36. https://doi.org/10.2215/CJN.03740907 PMID: 18003763
7. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992; 2(11):1608-16. Epub 1992/05/01. PMID: 1610982
8. Orth SR. Effects of Smoking on Systemic and Intrarenal Hemodynamics: Influence on Renal Function. Journal of the American Society of Nephrology. 2004; 15(1 suppl):S58-S63
9. Halimi JM, Giraudeau B, Vol S, Caces E, Nivet H, Lebranchu Y, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney international. 2000; 58(3):1285-92. Epub 2000/09/06. https://doi.org/10.1046/j.1523-1755.2000.00284.x PMID:10972692
10. Altay S, Onat A, Ozpamuk-Karadeniz F, Karadeniz Y, Kemaloglu-Oz T, Can G. Renal "hyperfiltrators" are at elevated risk of death and chronic diseases. BMC nephrology. 2014; 15(1):160. Epub 2014/10/04
11. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney international. 2007; 71 (2):159-66. https://doi.org/10.1038/sj.ki.5002017 PMID:17136030
12. Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet. 1994; 344(8917):237-9. Epub 1994/07/23. PMID: 7913161
13. Ram CV. Renovascular hypertension. Curr Opin Nephrol Hypertens. 1997; 6(6):575-9. Epub 1998/02/12. PMID: 9375273
14. Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J Hypertens Suppl. 1988; 6(1):S3-9. Epub 1988/11/01. PMID: 3216240
15. Textor SC. Atherosclerotic Renal Artery Stenosis: Flaws in Estimated Glomerular Filtration Rate and the Problem of Progressive Kidney Injury. Circulation: Cardiovascular Interventions. 2011; 4(3):213-5
16. Kennedy DJ, Colyer WR, Brewster PS, Ankenbrandt M, Burket MW, Nemeth AS, et al. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2003; 42(5):926-35
17. Mackay A, Brown JJ, Cumming AM, Isles C, Lever AF, Robertson JI. Smoking and renal artery stenosis. British medical journal. 1979; 2(6193):770. Epub 1979/09/29. PubMed Central PMCID: PMC1596397. PMID: 519191
18. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. The New England journal of medicine. 2014; 370(1):13-22. Epub 2013/11/20. https://doi.org/10.1056/NEJMoa1310753 PMID:24245566
19. Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2014; 64(6):821-35. Epub 2014/12/03
20. Thiebaut AC, Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Statistics in medicine. 2004; 23(24):3803-20. Epub 2004/12/08. https://doi.org/10.1002/sim.2098 PMID: 15580597
21. Commenges D, Letenneur L, Joly P, Alioum A, Dartigues JF. Modelling age-specific risk: application to dementia. Statistics in medicine. 1998; 17(17):1973-88. PMID: 9777690
22. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997; 145(1):72-80. PMID: 8982025
23. Duchesne T, Lawless J. Alternative time scales and failure time models. Lifetime Data Anal. 2000; 6 (2):157-79. PMID: 10851840
24. Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, et al. Antiatherosclerotic Effects of Long-Term Maximally Intensive Statin Therapy After Acute Coronary Syndrome: Insights From Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin. Arteriosclerosis, thrombosis, and vascular biology. 2014; 34(11):2465-72. Epub 2014/09/13. https://doi.org/10.1161/ATVBAHA.114.303932 PMID: 25212234
25. Cheng S, Claggett B, Correia AW, Shah AM, Gupta DK, Skali H, et al. Temporal trends in the population attributable risk for cardiovascular disease: the atherosclerosis risk in communities study. Circulation. 2014; 130(10):820-8. Epub 2014/09/12. PubMed Central PMCID: PMCPmc4161984. https://doi.org/10.1161/CIRCULATIONAHA.113.008506 PMID: 25210095
26. Malerba M, Montuschi P, Radaeli A, Pirisi M. Role of beta-blockers in patients with COPD: current perspective. Drug discovery today. 2015; 20(1):129-35. Epub 2014/09/23. https://doi.org/10.1016/j.drudis.2014.09.005 PMID: 25238736
27. Yamada Y, Noborisaka Y, Ishizaki M, Yamazaki M, Honda R, Yokoyama H, et al. Different association of cigarette smoking with GFR estimated from serum creatinine and that from serum cystatin C in the general population. Clinical and experimental nephrology. 2015; 19(4):669-77. https://doi.org/10.1007/s10157-014-1058-y PMID: 25407760
28. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney international. 2004; 65(4):1416-21. https://doi.org/10.1111/j.1523-1755.2004.00517.x PMID:15086483
29. Okura T, Jotoku M, Irita J, Enomoto D, Nagao T, Desilva VR, et al. Association between cystatin C and inflammation in patients with essential hypertension. Clinical and experimental nephrology. 2010; 14 (6):584-8. https://doi.org/10.1007/s10157-010-0334-8 PMID:20809110
30. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and endstage renal disease in men. The New England journal of medicine. 1996; 334(1):13-8. Epub 1996/01/04. https://doi.org/10.1056/NEJM199601043340103 PMID:7494564
31. Ritz E. Smoking and the kidney. In: Broe M, Porter G, Bennett W, Deray G, editors. Clinical Nephrotoxins: Springer US; 2008. p. 895-900
32. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003; 14(11):2934-41. Epub 2003/10/22. PMID: 14569104
33. Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2002; 40(4):704-12. Epub 2002/09/27
34. Wong CW, Wong TY, Cheng CY, Sabanayagam C. Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. Kidney international. 2014; 85(6):1290-302. https://doi.org/10.1038/ki.2013.491 PMID: 24336029
35. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Annals of internal medicine. 2000; 133 (8):585-91. Epub 2000/10/18. PMID: 11033585
36. Yoon HJ, Park M, Yoon H, Son KY, Cho B, Kim S. The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population. Hypertension research: official journal of the Japanese Society of Hypertension. 2009; 32(3):214-9. Epub 2009/03/06
37. Noborisaka Y. Smoking and chronic kidney disease in healthy populations. Nephro-urology monthly. 2013; 5(1):655-67. Epub 2013/04/12. PubMed Central PMCID: PMCPmc3614318. https://doi.org/10.5812/numonthly.3527 PMID: 23577327
38. Ishizaka N, Ishizaka Y, Toda E, Shimomura H, Koike K, Seki G, et al. Association between cigarette smoking and chronic kidney disease in Japanese men. Hypertension research: official journal of the Japanese Society of Hypertension. 2008; 31(3):485-92. Epub 2008/05/24
39. Sauriasari R, Sakano N, Wang DH, Takaki J, Takemoto K, Wang B, et al. C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population. Hypertension research: official journal of the Japanese Society of Hypertension. 2010; 33(11):1129-36. Epub 2010/08/13
40. Miyatake N, Moriyasu H, Sakano N, Tada S, Suzue T, Hirao T. Influence of cigarette smoking on estimated glomerular filtration rate (eGFR) in Japanese male workers. Acta medica Okayama. 2010; 64 (6):385-90. Epub 2010/12/22. PMID: 21173808
41. Noborisaka Y, Honda R, Ishizaki M, Nakata M, Yamada Y. Alcohol and cigarette consumption, renal function and blood pressure in middle-aged healthy men. Journal of human hypertension. 2007; 21 (12):966-8. Epub 2007/06/08. https://doi.org/10.1038/sj.jhh.1002242 PMID:17554344